EUROPEAN JOURNAL OF THERAPEUTICS, vol.23, no.3, pp.106-110, 2017 (ESCI)
Objective: Developments in transplantation procedures have led to an increase in the number of long-term survivors after hematopoietic stem cell transplantation (HSCT). In this study, we investigated non-malignant late side effects after autologous HSCT (AHSCT) in lymphoma patients.